Sentinel node micrometastases in breast cancer: Clinical outcome

Asia-Pacific Journal of Clinical Oncology

Volumn 6, Issue 4, 2010, Pages 330-341

  Kihara, Stephen M ^a   Giblett, Neil A ^b   Mcneil, Catriona ^c   Crea, Paul ^d  

^a HOPE HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITALS OF NORTH MIDLANDS NHS TRUST   (United Kingdom)

^c WESTMEAD HOSPITAL   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

Author keywords

Breast cancer; Isolated tumor cell; Micro metastatsis; Sentinel node

Indexed keywords

ANTHRACYCLINE;

ARTICLE; AUSTRALIA; BREAST CANCER; BREAST METASTASIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL PRACTICE; CONTROLLED STUDY; FEMALE; HORMONAL THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MICROMETASTASIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; TUMOR CELL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78649766508     PISSN: 17437555     EISSN: 17437563     Source Type: Journal    
DOI: 10.1111/j.1743-7563.2010.01325.x     Document Type: Article

References (39)

1. Soni N, Spillane A. Experience of sentinel node biopsy alone in early breast cancer without further axillary dissection in patients with negative sentinel node. ANZ J Surg 2005; 75: 292-9.
2. Krag D, Weaver D, Alex J, Fairbank J. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993; 2: 335-9.
3. Singh Ranger G, Mokbel K. The evolving role of sentinel lymph node biopsy for breast cancer. Eur J Surg Oncol 2003; 29: 423-5.
4. Lyman G, Giuliano A, Somerfield M etal. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in breast cancer. J Clin Oncol 2005; 23: 7703-20.
5. Smeets A, Christiaens M. Implications of the sentinel lymph node procedure for local and systemic adjuvant treatment. Curr Opin Oncol 2005; 17: 539-44.
6. Veronesi U, Paganelli G, Viale G. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003; 349: 546-53.
7. Langer S, Guenther J, Haigh P, DiFronzo L. Lymphatic mapping improves staging and reduces morbidity in women undergoing total mastectomy for breast carcinoma. Am Surg 2004; 70: 881-5.
8. Rietman J, Dijkstra P, Geertzen J. Treatment-related upper limb morbidity 1year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer. Ann Surg Oncol 2004; 11: 1018-24.
9. Armer J. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy. Lymphology 2004; 37: 73-91.
10. Nagashima T, Sakakibara M, Nakano S etal. Sentinel node micrometastasis and distant failure in breast cancer patients. Breast Cancer 2006; 13: 186-91.
11. Sobin L, Wittekind C (eds). International Union Against Cancer. TNM Classification of Malignant Tumours, 6th edn. Wiley-Liss, New York 2002.
12. Viale G, Maiorano E, Pruneri G. Predicting the risk of additional risk of additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg 2005; 241: 319-25.
13. Louis-Sylvestre C, Clough K, Asselein B. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15years of follow-up. J Clin Oncol 2004; 22: 97-101.
14. Colleoni M, Rotmensz N, Peruzzotti G etal. Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement. J Clin Oncol 2005; 23: 1379-89.
15. Goldhirsch A, Glick JH, Gelber RD, Coates AS, Thurlimann B, Senn HJ. Panel members meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 2005; 10: 1569-83.
16. Carter C, Allen C, Henson D. Relation of tumour size, lymph nodes status and survival in 24740 breast cancer cases. Cancer 1989; 63: 181-7.
17. Fisher E, Anderson S, Redmond C, Fisher B. Pathological findings from the National Surgical Adjuvant Breast Project Protocol B-06: 10year pathological and clinical prognostic discriminants. Cancer 1993; 71: 2507-14.
18. Morton D, Wen D, Wong J etal. Technical details of intra-operative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392-99.
19. Van der Veen H, Hoekstra O, Paul M, Cuesta M, Meijer S. Gamma-probe guided sentinel node biopsy to select patients with melanoma for lymphadenectomy. Br J Surg 1994; 81: 1769-70.
20. Giuliano A, Haigh P, Brennan M etal. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 2000; 18: 2553-9.
21. Veronesi U, Galimberti V, Zurrida S etal. Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer. Eur J Cancer 2001; 37: 454-8.
22. Huang J, Barbera L, Brouwers M etal. Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol 2003; 21: 555-63.
23. Fisher B, Redmond C, Fisher E etal. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985; 312: 1245-8.
24. Early Breast Cancer Trialists' Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomised trial. Lancet 1998; 352: 930-42.
25. Duric V, Stockler M. Patients preferences for adjuvant chemotherapy in early breast cancer: a review of what makes it worthwhile. Lancet Oncol 2001; 2: 691-7.
26. Early Breast Cancer Trialists' Collaborative Group. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer: an overview of 61 randomised trials among 28896 women. N Engl J Med 1988; 319: 1681-92.
27. Early Breast Cancer Trialists' Collaborative Group. Treatment of Early Breast Cancer, Vol 1: Worldwide Evidence 1985-1990. Oxford University Press, Oxford 1990.
28. Early Breast Cancer Trialists' Collaborative Group. Systematic treatment of early breast cancer by hormonal, cytotoxic or immune therapy: 133 randomised trials involving 31000 recurrences and 24000 deaths among 75000 women. Lancet 1992; 339: 1-15.
29. Lippman M, Hayes D. Adjuvant therapy for all patients with breast cancer? J Natl Cancer I 2001; 93: 80-2.
30. Coates A, Simes R. Patient assessment of adjuvant treatment in operable breast cancer. In: Williams CJ (ed.). Introducing New Treatments for Cancer: Practical, Ethical, and Legal Problems. John Wiley & Sons, New York 1992; 447-58.
31. Ravidin P, Siminoff I, Harvey J. Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy. J Clin Oncol 1998; 16: 515-21.
32. Lindley C, Vasa S, Sawyer W, Winer E. Quality of life and preferences for treatment following systemic adjuvant therapy for early stage breast cancer. J Clin Oncol 1998; 16: 380-7.
33. Adjuvant! Online [Online]. 2006 [updated 15 August 2009; cited 12 April 2007]; Available from.
34. Olivotto I, Bajdik C, Ravdin P etal. Population-based validation of the prognostic model ADJUVANT! for early breast cancer. J Clin Oncol 2005; 23: 2716-25.
35. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
36. Tracey E, Chen S, Baker D, Bishop J, Jelfs P. Cancer in New South Wales incidence and mortality report. NSW Cancer Registry. Cancer Institute NSW [Online] 2006 Nov Page 34 [updated 15 August 2009; cited 12 April 2007]; Available from.
37. Tracey E, Chen S, Baker D, Bishop J, Jelfs P. Cancer in New South Wales Incidence and Mortality Report. NSW Cancer Registry. Cancer Institute NSW [Online] 2006 Nov Page 35 [updated 15 August 2009; cited 12 April 2007]; Available from.
38. West Midlands Cancer Intelligence Unit. Breast Cancer in the West Midlands. [Online]. 2006 Oct [updated 15 August 2009; cited 12 April 2007]; Available from.
39. Singletary S, Allred C, Ashley P etal. Revision of the American joint committee on cancer staging system for breast cancer. J Clin Oncol 2002; 20: 3628-36.